Literature DB >> 27880980

Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation.

Hideki Nakasone1, Shigeo Fuji2, Kimikazu Yakushijin3, Makoto Onizuka4, Akihito Shinohara5, Kazuteru Ohashi6, Koichi Miyamura7, Naoyuki Uchida8, Minoko Takanashi9, Tatsuo Ichinohe10, Yoshiko Atsuta11,12, Takahiro Fukuda2, Masao Ogata13.   

Abstract

Total body irradiation (TBI) has been thought to promote donor cell engraftment in allogeneic hematopoietic cell transplantation (HCT) from alternative donors. However, recent progress in HCT strategies may affect the clinical significance of TBI on neutrophil engraftment. With the use of a Japanese transplant registry database, we analyzed 3933 adult recipients (>15 y.o.) who underwent HCT between 2006 and 2013 from an 8/8 HLA-matched unrelated bone marrow donor (MUD, n = 1367), an HLA-mismatched unrelated bone marrow donor (MMUD, n = 1102), or unrelated cord blood (CBT, n = 1464). Conditioning regimens were divided into five groups: High-TBI-(>8Gy), Low-TBI- (≤8Gy), and no-TBI-myeloablative conditioning (MAC), and Low-TBI- and no-TBI-reduced-intensity conditioning (RIC). In both MUD and MMUD, neutrophil engraftment rate was >90% in each of the five conditioning groups, and TBI was not associated with prompt neutrophil engraftment in multivariate analyses. Conversely, in CBT, TBI regimens had a higher rate of day-30 neutrophil engraftment than no-TBI-regimens: 78% in High-TBI-MAC, 83% in Low-TBI-MAC, and 76% in Low-TBI-RIC versus 65% in No-TBI-MAC, and 68% in No-TBI-RIC (P < .001). Multivariate analyses in CBT demonstrated that TBI-regimens were significantly associated with a higher rate of neutrophil engraftment. Subsequently focusing on CBT patients alone, TBI-regimens were significantly associated with a higher rate of neutrophil engraftment in patients who received CBT with a 4/6 or less HLA allele-match, or who had anti-HLA antibodies. In summary, TBI-regimens had no impact on neutrophil engraftment in the current practice of unrelated bone marrow transplantation. However, in CBT, TBI is still necessary to enhance engraftment.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 27880980     DOI: 10.1002/ajh.24613

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen.

Authors:  Takumi Hoshino; Satoru Takada; Nahoko Hatsumi; Toru Sakura
Journal:  Int J Hematol       Date:  2019-02-08       Impact factor: 2.490

2.  Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT.

Authors:  Yu Akahoshi; Satoshi Nishiwaki; Yasuyuki Arai; Kaito Harada; Yuho Najima; Yoshinobu Kanda; Katsuhiro Shono; Shuichi Ota; Takahiro Fukuda; Naoyuki Uchida; Souichi Shiratori; Masatsugu Tanaka; Junji Tanaka; Yoshiko Atsuta; Shinichi Kako
Journal:  Bone Marrow Transplant       Date:  2020-05-23       Impact factor: 5.483

3.  Drug monitoring for mycophenolic acid in graft-vs-host disease prophylaxis in cord blood transplantation.

Authors:  Hiroyuki Muranushi; Junya Kanda; Yasuyuki Arai; Takero Shindo; Masakatsu Hishizawa; Takashi Yamamoto; Tadakazu Kondo; Kohei Yamashita; Kazuo Matsubara; Akifumi Takaori-Kondo
Journal:  Br J Clin Pharmacol       Date:  2020-05-30       Impact factor: 4.335

4.  Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases.

Authors:  Akira Nishimura; Yuki Aoki; Yasuyoshi Ishiwata; Takuya Ichimura; Junichi Ueyama; Yuta Kawahara; Takahiro Tomoda; Maiko Inoue; Kazuaki Matsumoto; Kento Inoue; Haruka Hiroki; Shintaro Ono; Motoi Yamashita; Tsubasa Okano; Mari Tanaka-Kubota; Miho Ashiarai; Satoshi Miyamoto; Reiji Miyawaki; Chika Yamagishi; Mari Tezuka; Teppei Okawa; Akihiro Hoshino; Akifumi Endo; Masato Yasuhara; Takahiro Kamiya; Noriko Mitsuiki; Toshiaki Ono; Takeshi Isoda; Masakatsu Yanagimachi; Daisuke Tomizawa; Masayuki Nagasawa; Shuki Mizutani; Michiko Kajiwara; Masatoshi Takagi; Hirokazu Kanegane; Kohsuke Imai; Tomohiro Morio
Journal:  J Clin Immunol       Date:  2021-02-01       Impact factor: 8.317

Review 5.  A concise review on factors influencing the hematopoietic stem cell transplantation main outcomes.

Authors:  Mohammad Rafiee; Mohammad Abbasi; Hassan Rafieemehr; Amin Mirzaeian; Mohieddin Barzegar; Vahid Amiri; Shaghayegh Shahsavan; Mohammad Hossein Mohammadi
Journal:  Health Sci Rep       Date:  2021-05-07

6.  Phase II study of intrabone single unit cord blood transplantation for hematological malignancies.

Authors:  Makoto Murata; Yoshinobu Maeda; Masayoshi Masuko; Yasushi Onishi; Tomoyuki Endo; Seitaro Terakura; Yuichi Ishikawa; Chisako Iriyama; Yoko Ushijima; Tatsunori Goto; Nobuharu Fujii; Mitsune Tanimoto; Hironori Kobayashi; Yasuhiko Shibasaki; Noriko Fukuhara; Yoshihiro Inamoto; Ritsuro Suzuki; Yoshihisa Kodera; Tadashi Matsushita; Hitoshi Kiyoi; Tomoki Naoe; Tetsuya Nishida
Journal:  Cancer Sci       Date:  2017-06-29       Impact factor: 6.716

7.  National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group.

Authors:  Hiroki Kawaguchi; Toshinori Soejima; Naoya Ishibashi; Takeshi Akiba; Masatoshi Hasegawa; Kouichi Isobe; Hitoshi Ito; Michiko Imai; Yasuo Ejima; Masaharu Hata; Keisuke Sasai; Emiko Shimoda; Masahiko Oguchi; Tetsuo Akimoto
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

8.  Does Total Body Irradiation Have a Favorable Impact on Thrombocyte Engraftment as per Neutrophil Engraftment in Allogeneic Stem Cell Transplantation?

Authors:  Bahar Uncu Ulu; Tuğçe Nur Yiğenoğlu; Derya Şahin; Semih Başcı; Dicle İskender; Yasemin Adaş; Ebru Atasever Akkaş; Tuba Hacıbekiroğlu; Merih Kızıl Çakar; Mehmet Sinan Dal; Fevzi Altuntaş
Journal:  Cureus       Date:  2021-11-11

9.  Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study.

Authors:  Zimin Sun; Huilan Liu; Chenhui Luo; Liangquan Geng; Changcheng Zheng; Baolin Tang; Xiaoyu Zhu; Juan Tong; Xingbing Wang; Kaiyang Ding; Xiang Wan; Lei Zhang; Wen Yao; Kaiding Song; Xuhan Zhang; Yue Wu; Huizhi Yang; Yongsheng Han; Xin Liu; Weibo Zhu; Jingsheng Wu; Zuyi Wang
Journal:  Int J Cancer       Date:  2018-03-12       Impact factor: 7.396

10.  Autologous Hematopoietic Recovery after Unrelated Umbilical Cord Blood Transplantation with Myeloablative Conditioning for Acute Myelogenous Leukemia.

Authors:  Ayumi Gomyo; Hideki Nakasone; Hidenori Wada; Shunto Kawamura; Nozomu Yoshino; Junko Takeshita; Kazuki Yoshimura; Yukiko Misaki; Aki Tanihara; Yu Akahoshi; Machiko Kusuda; Masaharu Tamaki; Koji Kawamura; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  Intern Med       Date:  2020-06-15       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.